Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Doris Barcellona"'
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 3, Iss 2 (2024)
Stroke is the third leading cause of death and the most important reason for disability. It is worth noting that 60% of all stroke deaths involve women. This review aims to revise the prothrombotic hemostatic alterations in hypertension along with th
Externí odkaz:
https://doaj.org/article/57ba7854a1d94bae83b9b42f6a278f68
Publikováno v:
Journal of Pediatric and Neonatal Individualized Medicine, Vol 13, Iss 1, Pp e130117-e130117 (2024)
The hemostatic system (HS) is crucial for human survival, both by preventing excessive bleeding and also through close links to the immune system. Both systems cooperate to defend us from attacks by microorganisms and viruses. However, the behavior o
Externí odkaz:
https://doaj.org/article/450c5bf97d314dafa5c340817e21a825
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 24, p 7574 (2023)
Background: Direct oral anticoagulants (DOACs) are widely used in patients with atrial fibrillation and venous thromboembolism. The lack of the need for laboratory monitoring and a better safety than vitamin K antagonists (VKAs) has probably changed
Externí odkaz:
https://doaj.org/article/638a7b8178514a17a94cea1126a2d131
Autor:
Daniela Poli, Riccardo Tartaglia, Doris Barcellona, Paolo Bucciarelli, Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 2, Iss 1 (2023)
Clinical research is vital in supporting evidence-based practice. However, several barriers make participation in research difficult. We performed a survey to evaluate the attitude to research of the members of the Italian Anticoagulation Clinics. Th
Externí odkaz:
https://doaj.org/article/905c889ec07d415a988d6cafe4b0f007
Autor:
Francesco Marongiu, Dimitrios Marco Ntoukas, Luigi Barberini, Maria Filomena Ruberto, Maria Sebastiana Piras, Maria Conti, Maria Luisa Di Martino, Mario Mura, Silvia Marongiu, Maria Luigia Vannini, Mattia Lillu, Monica Piras, Daniela Fanni, Lara Fenu, Carmen Porcu, Doris Barcellona, Gavino Faa, Terenzio Congiu
Publikováno v:
Journal of Public Health Research (2021)
Background: Clot characterization is, to the present days, a multimodal approach: scanning the clot by electron microscopy (SEM) is helpful for the visualization of fibrin structure along with laboratory parameters such as the clot waveform analysis
Externí odkaz:
https://doaj.org/article/f6f1c447511c487d8a0722cde325819a
Autor:
Francesco Marongiu, Doris Barcellona
Publikováno v:
TH Open, Vol 04, Iss 04, Pp e300-e302 (2020)
Externí odkaz:
https://doaj.org/article/7a26f8fafc724599b00d5d0153b0e66f
Autor:
Daniela Fanni, Francesco Angotzi, Clara Gerosa, Doris Barcellona, Giancarlo Senes, Federica Lai, Giovanni Martino, Stefano Ascani, Vassilios Fanos, Gavino Faa
Publikováno v:
Journal of Pediatric and Neonatal Individualized Medicine, Vol 9, Iss 1, Pp e090118-e090118 (2020)
Before birth, different organs retain hematopoiesis. The liver is involved in the 6th-8th week of gestation. The hepatic hematopoietic stem cell (HSC) niche begins when HSCs colonize the liver and make contact with sinusoidal endothelial cells. The a
Externí odkaz:
https://doaj.org/article/ac91fb95819947b3aee6544b1f6d0621
Autor:
Doris Barcellona, Francesco Marongiu
Publikováno v:
Journal of Pediatric and Neonatal Individualized Medicine, Vol 9, Iss 1, Pp e090106-e090106 (2019)
The hemostatic system is a complex ancestral pathway physiologically dedicated to protect the individual from bleeding. It starts immediately after an endothelial injury. Platelets and blood coagulation act synergically to provide a strength clot abl
Externí odkaz:
https://doaj.org/article/bf9eae21ac98443f8e5c8df97632afcb
Autor:
Francesco Marongiu, Doris Barcellona
Publikováno v:
Seminars in Thrombosis and Hemostasis.
Publikováno v:
Seminars in Thrombosis and Hemostasis.
The development of oral contraceptives (OCs) began in 1921 and continued in the following years until the first regulatory approval from the Food and Drug Administration was granted in 1960. However, it took several years to realize that OCs presente